Request TOC and Sample - Companion Diagnostics for Oncology Market by Product (Product, Service), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS, Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Other Technologies), by Disease (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma,, Prostate Cancer, Others) and by End User (Hospitals, Pathology/Diagnostic Laboratory, Academic Medical Center): Global Opportunity Analysis and Industry Forecast, 2023-2032

Companion Diagnostics for Oncology Market (2023-2032)

by Product (Product, Service), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS, Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Other Technologies), by Disease (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer, Others) and, by End User (Hospitals, Pathology/Diagnostic Laboratory, Academic Medical Center)